BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37639080)

  • 21. Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia.
    Paridaens D; Beekhuis H; van Den Bosch W; Remeyer L; Melles G
    Br J Ophthalmol; 2001 Jun; 85(6):658-61. PubMed ID: 11371482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.
    Yousef YA; Finger PT
    Ophthalmology; 2012 Feb; 119(2):233-40. PubMed ID: 22189448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
    Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
    Finger PT; Sedeek RW; Chin KJ
    Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Primary Acquired Melanosis, Nevus, and Conjunctival Melanoma.
    Kao A; Afshar A; Bloomer M; Damato B
    Cancer Control; 2016 Apr; 23(2):117-25. PubMed ID: 27218788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective review of conjunctival melanoma: Presentation, treatment and evolution.
    Pacheco GE; Garcia-Onrubia L; Garcia-Alvarez C; Muñoz MF; Garcia-Lagarto E; Perez DM; Alonso P; Saornil MA
    Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):218-224. PubMed ID: 30846247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Giant conjunctival nevus: clinical features and natural course in 32 cases.
    Shields CL; Regillo AC; Mellen PL; Kaliki S; Lally SE; Shields JA
    JAMA Ophthalmol; 2013 Jul; 131(7):857-63. PubMed ID: 23702735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
    Finger PT; Czechonska G; Liarikos S
    Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
    Colby KA; Nagel DS
    Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extensive conjunctival melanoma successfully treated with surgical resection and pre- and postoperative topical mitomycin C.
    Mazzini C; Pieretti G; Vicini G; Nicolosi C; Virgili G; Giansanti F
    Eur J Ophthalmol; 2021 Nov; 31(6):NP71-NP74. PubMed ID: 32674607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of conjunctival melanoma.
    Damato B; Coupland SE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1227-39. PubMed ID: 19761427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjunctival melanoma in patients with xeroderma pigmentosum: a series of four cases.
    Vasanthapuram VH; Kaliki S
    Int Ophthalmol; 2020 May; 40(5):1143-1146. PubMed ID: 31933024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Joint Committee on Cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
    Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
    Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathology and prognostic factors of conjunctival melanoma].
    Berta-Antalics AI; Kruse FE; Holbach L
    Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
    Lommatzsch PK; Werschnik C
    Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
    Cid-Bertomeu P; Huerva V
    Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma.
    Fabian ID; Thaung C; AlHarby L; Sisley K; Mudhar HS; Doherty RE; Stacey AW; Arora AK; Cohen VML; Sagoo MS
    Am J Ophthalmol; 2017 Sep; 181():97-105. PubMed ID: 28673748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment modalities for conjunctival melanoma].
    Krause L; Mladenova A; Bechrakis NE; Kreusel KM; Plath T; Moser L; Foerster M
    Klin Monbl Augenheilkd; 2009 Dec; 226(12):1012-6. PubMed ID: 20108195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjunctival Melanoma in Chinese Patients: Local Recurrence, Metastasis, Mortality, and Comparisons With Caucasian Patients.
    Zhou C; Wang Y; Jia R; Fan X
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5452-5459. PubMed ID: 29059312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.